Herpes simplex virus type 1-vaccinia virus recombinant expressing glycoprotein B: protection from acute and latent infection.
Willey
D E
DE
Department of Neurology, City of Hope National Medical Center, Duarte, California 91010-0269.
Cantin
E M
EM
Hill
L R
LR
Moss
B
B
Notkins
A L
AL
Openshaw
H
H
D000208:Acute Disease; D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D002460:Cell Line; D005123:Eye / Q000382:microbiology; D007635:Keratitis, Dendritic / Q000517:prevention & control*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D012008:Recurrence; D018139:Simplexvirus / Q000276:immunology*; D012668:Trigeminal Ganglion / Q000382:microbiology; D014611:Vaccination; D014612:Vaccines / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000276:immunology*; D014616:Vaccinia virus / Q000276:immunology; D014709:Vero Cells; D014759:Viral Envelope Proteins / Q000276:immunology*; D014765:Viral Vaccines / Q000276:immunology*
D000914:Antibodies, Viral; D014612:Vaccines; D014614:Vaccines, Synthetic; D014759:Viral Envelope Proteins; D014765:Viral Vaccines; C040495:glycoprotein B, Simplexvirus; C039447:glycoprotein D, Human herpesvirus 1